IDT Australia Ltd (AU:IDT) — Market Cap & Net Worth
Market Cap & Net Worth: IDT Australia Ltd (IDT)
IDT Australia Ltd (AU:IDT) has a market capitalization of $14.52 Million (AU$20.52 Million) as of September 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26173 globally and #1173 in its home market, demonstrating a 2.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IDT Australia Ltd's stock price AU$0.05 by its total outstanding shares 427425574 (427.43 Million). Also see IDT asset base for a full breakdown of the balance sheet.
IDT Australia Ltd Market Cap History: 2015 to 2026
IDT Australia Ltd's market capitalization history from 2015 to 2026. Data shows change from $111.90 Million to $14.52 Million (-16.95% CAGR). Also see IDT cash generation efficiency for how efficiently the company converts equity into cash flow.
IDT Australia Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IDT Australia Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check IDT Australia Ltd share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.78x
IDT Australia Ltd's market cap is 0.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $54.44 Million | $7.61 Million | -$4.01 Million | 7.15x | N/A |
| 2017 | $27.22 Million | $9.54 Million | -$773.00K | 2.85x | N/A |
| 2018 | $43.85 Million | $12.89 Million | -$16.98 Million | 3.40x | N/A |
| 2019 | $42.34 Million | $12.13 Million | -$6.08 Million | 3.49x | N/A |
| 2020 | $55.95 Million | $14.10 Million | -$1.92 Million | 3.97x | N/A |
| 2021 | $77.12 Million | $15.99 Million | $2.10 Million | 4.82x | 36.67x |
| 2022 | $24.19 Million | $12.11 Million | -$1.16 Million | 2.00x | N/A |
| 2023 | $33.27 Million | $6.93 Million | -$8.50 Million | 4.80x | N/A |
| 2024 | $33.27 Million | $13.23 Million | -$5.41 Million | 2.52x | N/A |
| 2025 | $15.42 Million | $19.77 Million | -$8.06 Million | 0.78x | N/A |
Competitor Companies of IDT by Market Capitalization
Companies near IDT Australia Ltd in the global market cap rankings as of September 20, 2026. Review IDT Australia Ltd tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to IDT Australia Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
IDT Australia Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, IDT Australia Ltd's market cap moved from $111.90 Million to $ 14.52 Million, with a yearly change of -16.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$14.52 Million | -5.88% |
| 2025 | AU$15.42 Million | -53.64% |
| 2024 | AU$33.27 Million | 0.00% |
| 2023 | AU$33.27 Million | +37.50% |
| 2022 | AU$24.19 Million | -68.63% |
| 2021 | AU$77.12 Million | +37.84% |
| 2020 | AU$55.95 Million | +32.14% |
| 2019 | AU$42.34 Million | -3.45% |
| 2018 | AU$43.85 Million | +61.11% |
| 2017 | AU$27.22 Million | -50.00% |
| 2016 | AU$54.44 Million | -51.35% |
| 2015 | AU$111.90 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of IDT Australia Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.52 Million USD |
| MoneyControl | $14.52 Million USD |
| MarketWatch | $14.52 Million USD |
| marketcap.company | $14.52 Million USD |
| Reuters | $14.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IDT Australia Ltd
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and ase… Read more